Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D David O'toole


  • Chief Financial Officer at Opiant Pharmaceuticals Inc. (OPNT), 2019-08-15
  • Director at Capnia Inc. (CAPN), 2017-04-24
  • Svp & Chief Financial Officer at Codexis Inc (CDXS), 2013-09-06
  • Director at Medicinova Inc (MNOV), 2012-05-30
  • Vp And Chief Financial Officer at Response Genetics Inc (RGDX), 2012-02-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OPNT $15.20 1,000 Officer 8,015 2019-08-15 Filing
OPNT $15.46 1,000 Officer 7,015 2019-08-13 Filing
OPNT $15.39 1,000 Officer 6,015 2018-08-14 Filing
OPNT $16.40 15 Officer 5,015 2018-08-14 Filing
OPNT $16.95 2,000 Officer 5,000 2018-05-16 Filing